Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.
Open | $14.94 |
Close | - |
Volume / Avg. | 13.89K / 47.04K |
Day Range | $14.54 - $14.94 |
52 Wk Range | 7.58 - 21.44 |
Market Cap | $191.65M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 7.32% |
Days to Cover | 20.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Greenwich LifeSciences (NASDAQ:GLSI) through any online brokerage.
Other companies in Greenwich LifeSciences’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Atossa Therapeutics (NASDAQ:ATOS).
Greenwich LifeSciences has a consensus price target of $38.00.
The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $14.58 last updated September 23, 2024 at 1:25 PM EDT.
There are no upcoming dividends for Greenwich LifeSciences.
Greenwich LifeSciences’s Q3 earnings are confirmed for Thursday, October 17, 2024.
There is no upcoming split for Greenwich LifeSciences.
Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.